Stay updated with breaking news from Dash Conference. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The panel reviews axatilimab, an emerging agent for chronic GVHD under clinical studies. The experts explore findings from the Agave-201 study, highlighting potential challenges of intravenous administration and axatilimab’s unique mechanisms.
The network’s physicians’ research reports were selected after a thorough peer review process....
Στον Δρόμο του Σαββάτου 3 Ιουλίου Ελλάδα 04 Ιουλίου 2021 Πρόβες γκετοποίησης Στήνουν «απαρτχάιντ» με ακραία διχαστικά μέτρα, ενώ απαιτείται καθολική αντιμετώπιση, ενότητα και δημοκρατική συνεννόηση των κοινωνιών – Αξιοποιούν την πανδημία για την καθυπόταξη των πληθυσμών – Η ελευθερία δεν εξαγοράζεται Γ...
Follow us Get news via Twitter Become a fan Join us on Facebook Subscribe Net News via RSS Jacobs Media's Paul Jacobs Honored With Outstanding Alumni Award From Michigan State April 16, 2021 at 1:20 AM (PT) Paul Jacobs JACOBS MEDIA VP/GM and JACAPPS President PAUL JACOBS has been honored by MICHIGAN STATE UNIVERSITY's School Of Communication, Arts and Sciences with its OUTSTANDING ALUMNI AWARD. The announcement was made by Dean PRABU DAVID. JACOBS is one of five MSU graduates receiving the honor at the school’s annual ALUMNI AWARDS CELEBRATION PROGRAM, which wil...
Operator Welcome to the Fate Therapeutics Fourth Quarter 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section on Fate's website at fatetherapeutics.com. As a reminder, today's call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics. The floor is yours. Scott Wolchko -- President and Chief Executive Officer Thank you. Good afternoon, and thanks everyone for joining us for the Fate Therapeutics fourth quarter 2020 financial results ...